[Protocol for the treatment of chronic viral hepatitis].
Dalmi
Lajos
L
Gervain
Judit
J
Horváth
Gábor
G
Hunyady
Béla
B
Ibrányi
Endre
E
Makara
Mihály
M
Pár
Alajos
A
Szalay
Ferenc
F
Tornai
István
I
Telegdy
László
L
D000225:Adenine / Q000031:analogs & derivatives / Q000627:therapeutic use; D000465:Algorithms; D000998:Antiviral Agents / Q000627:therapeutic use*; D002985:Clinical Protocols; D016174:Hepacivirus / Q000235:genetics / Q000276:immunology / Q000302:isolation & purification*; D006515:Hepatitis B virus / Q000235:genetics / Q000276:immunology / Q000302:isolation & purification*; D019694:Hepatitis B, Chronic / Q000188:drug therapy*; D019698:Hepatitis C, Chronic / Q000188:drug therapy*; D006801:Humans; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000627:therapeutic use; D007372:Interferons / Q000627:therapeutic use*; D019259:Lamivudine / Q000627:therapeutic use; D063065:Organophosphonates / Q000627:therapeutic use; D011092:Polyethylene Glycols / Q000627:therapeutic use; D011994:Recombinant Proteins; D012254:Ribavirin / Q000627:therapeutic use
D000998:Antiviral Agents; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D063065:Organophosphonates; D011994:Recombinant Proteins; D019259:Lamivudine; D011092:Polyethylene Glycols; D012254:Ribavirin; D007372:Interferons; D000225:Adenine; C100416:peginterferon alfa-2a; C106812:adefovir dipivoxil